A study in the Journal of the National Cancer Institute has identified specific genes associated with increased risk for triple-negative breast cancer, providing the basis for better risk management.
The global age-standardized lung cancer mortality rate among women is projected to increase by 43 percent from 2015 to 2030, according to an analysis of data from 52 countries. The global age-standardized breast cancer mortality rate is projected to decrease by 9 percent in the same time frame. The data was published in Cancer Research.
Novocure said the results of its INNOVATE phase II pilot study have been published in Gynecologic Oncology. The INNOVATE study was a prospective, single-arm study testing the feasibility, safety and preliminary efficacy of Tumor Treating Fields combined with weekly paclitaxel in recurrent ovarian cancer.
The Masonic Cancer Center of the University of Minnesota received an overall rating of “outstanding” from NCI in the course of renewal of its five-year Cancer Center Support Grant and reconfirmation of its comprehensive status.
Dominic Seraphin was named vice president of Strategic Alliances & Network, a group dedicated to expanding access to care available at Moffitt Cancer Center. He will also manage business development and operations.
Constanza Martinez Piñanez, a psychosomatic medicine physician, has joined the Patient Support Services team at
House committee defoliates NIH funding for WHO program that declares weedkiller Roundup a carcinogen
The House Committee on Appropriations has withheld funding for the WHO International Agency for Research on Cancer—which receives about $2 million from the United States per year—because of controversy over the agency's label for glyphosate, a chemical commonly used in weedkillers.
Researchers at Project GENIE, the largest publicly available genomic database in the U.S., understand what it takes to convert sequencing data into real-world evidence: a lot of money, manpower, and data harmonization, said Shawn Sweeney, director of the American Association for Cancer Research Project GENIE Coordinating Center.
With 11 new partners, AACR’s Project GENIE to make available genomic data from 60,000 tumors by 2019
Project GENIE, already the largest publicly available genomic data repository in the U.S., is on track to publish information on 60,000 sequenced tumors—derived from an international network largely comprised of academic cancer centers—by January 2019.
Gene Editing Institute of Christiana Care Health System's Helen F. Graham Cancer Center & Research Institute licensed its gene editing technology to Jerusalem-based NovellusDx to improve the efficiency and speed of NovellusDx's cancer diagnostic screening tools.
